To determine whether the loss of IPMK exacerbates the NASH phenotype, we fed wild-type (WT) and liver-specific IPMK knockout (LKO) mice an MCDD, and assessed liver histology, hepatocellular injury, and inflammation. The gene discussed is IPMK; the disease is metabolic dysfunction-associated steatohepatitis.